Holen Sie sich die Stockscreener-App
169.01
0.70%
1.298
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$167.71
Offen:
$165.73
24-Stunden-Volumen:
251.25K
Relative Volume:
0.20
Marktkapitalisierung:
$33.37B
Einnahmen:
$15.92B
Nettoeinkommen (Verlust:
$2.13B
KGV:
16.44
EPS:
10.2827
Netto-Cashflow:
$2.47B
1W Leistung:
+0.93%
1M Leistung:
+3.07%
6M Leistung:
+6.62%
1J Leistung:
+9.51%
1-Tages-Spanne:
$165.30
$169.00
1-Wochen-Bereich:
$164.07
$170.12
52-Wochen-Spanne:
$117.56
$177.66
Raymond James Financial Inc Stock (RJF) Company Profile
Firmenname
Raymond James Financial Inc
Sektor
Branche
Telefon
727-567-1000
Adresse
880 CARILLON PKWY, ST PETERSBURG, FL
Vergleichen Sie RJF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RJF
Raymond James Financial Inc
|
169.00 | 33.12B | 15.92B | 2.13B | 2.47B | 10.28 |
|
BLK
Blackrock Inc
|
1,088.14 | 168.35B | 23.50B | 6.37B | 4.02B | 38.48 |
|
BX
Blackstone Inc
|
156.78 | 121.90B | 14.00B | 5.40B | 2.05B | 3.4868 |
|
KKR
Kkr Co Inc
|
134.56 | 120.02B | 17.71B | 5.26B | 8.31B | 2.3473 |
|
BN
Brookfield Corporation
|
47.84 | 106.98B | 76.07B | 1.66B | -2.78B | 0.3615 |
|
BAM
Brookfield Asset Management Ltd
|
53.99 | 86.98B | 3.54B | 1.97B | 1.70B | 1.6234 |
Raymond James Financial Inc Stock (RJF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Fortgesetzt | UBS | Neutral |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-04-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-01-06 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-09 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-09-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-01-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-04 | Eingeleitet | TD Cowen | Market Perform |
| 2024-01-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-19 | Eingeleitet | JP Morgan | Neutral |
| 2023-09-11 | Eingeleitet | BofA Securities | Buy |
| 2023-07-21 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-12-19 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-11-22 | Eingeleitet | UBS | Neutral |
| 2022-10-19 | Eingeleitet | Credit Suisse | Neutral |
| 2022-10-12 | Eingeleitet | Citigroup | Neutral |
| 2022-01-28 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2022-01-10 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-07-21 | Eingeleitet | Jefferies | Buy |
| 2021-01-15 | Hochstufung | Wells Fargo | Underweight → Overweight |
| 2021-01-05 | Hochstufung | Goldman | Sell → Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Neutral |
| 2020-06-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-01 | Herabstufung | Compass Point | Buy → Neutral |
| 2020-03-25 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-03-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-24 | Herabstufung | Goldman | Neutral → Sell |
| 2020-03-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-04 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-03-06 | Eingeleitet | Argus | Buy |
| 2018-11-27 | Eingeleitet | Goldman | Neutral |
| 2018-10-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-27 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2018-07-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-05-16 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-27 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-04-10 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-02-27 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
Alle ansehen
Raymond James Financial Inc Aktie (RJF) Neueste Nachrichten
Raymond James and Boys & Girls Clubs of America Announce $10 Million Partnership to Advance Academic Success for America’s Youth - Boys & Girls Clubs of America
Raymond James reiterates Strong Buy on Aardvark Therapeutics stock with $47 target - Investing.com
Raymond James reiterates Outperform rating on Alnylam stock at $472 target - Investing.com UK
Raymond James sees alternative lenders as winners if Trump’s credit card cap passes - Investing.com
Inside Raymond James Financial: How a Quiet Powerhouse Is Re?Engineering Full?Stack Wealth Managemen - AD HOC NEWS
Wells Fargo Lifts Estée Lauder (EL) Target as Raymond James Names It a 2026 Top Pick - Yahoo Finance
Panic Selling: Is Raymond James Financial Inc stock a safe haven assetTrade Volume Report & Risk Managed Investment Signals - moha.gov.vn
SG Americas Securities LLC Sells 23,848 Shares of Raymond James Financial, Inc. $RJF - MarketBeat
With 79% ownership, Raymond James Financial, Inc. (NYSE:RJF) boasts of strong institutional backing - Yahoo Finance
Raymond James Financial Inc (NYSE:RJF) Shows Strong Technical Setup for Potential Breakout - Chartmill
Raymond James Financial, Inc. $RJF Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Marvell (MRVL) Gets Strong Buy as Raymond James Backs XConn Acquisition - Yahoo Finance
Raymond James Initiates Coverage of BridgeBio Oncology Therapeutics (BBOT) with Outperform Recommendation - Nasdaq
Ag Growth International (TSE:AFN) Raised to "Outperform" at Raymond James Financial - MarketBeat
Why TowneBank (TOWN) Is Up 5.4% After Raymond James Reaffirms Buy On Revenue Growth – And What's Next - Yahoo Finance
2026 Investing OutlookRaymond JamesCommentaries - Advisor Perspectives
Raymond James Initiates BridgeBio Oncology Therapeutics at Outperform With $24 Price Target - MarketScreener
BridgeBio Oncology stock initiated with Outperform rating at Raymond James By Investing.com - Investing.com UK
Raymond James reiterates Strong Buy on Doximity stock amid AI competition - Investing.com
Raymond James Financial increases quarterly dividend by 8% - MSN
Is Raymond James Financial Inc. Depositary stock nearing a technical breakoutJuly 2025 Macro Moves & Verified Swing Trading Watchlist - ulpravda.ru
Raymond James reiterates Market Perform rating on Coinbase stock - Investing.com
Raymond James sees strong growth for Doximity stock amid stable pharma budgets - Investing.com UK
Ardelyx stock price target raised to $19 from $16 at Raymond James - Investing.com
JPMorgan Raises Raymond James Financial Price Target to $182 From $180 - marketscreener.com
Is Raymond James Financial Inc. stock a top pick in earnings season2025 Performance Recap & Free Community Consensus Stock Picks - ulpravda.ru
Troy J. Forman recognized by Raymond James Financial Services - Local News Digital
Can Raymond James Financial Inc. stock weather global recession2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - ulpravda.ru
Raymond James examines the state of U.S. inflation ahead of data deluge - Investing.com Canada
Raymond James Financial, Inc. $RJF is Harfst & Associates Inc.'s Largest Position - MarketBeat
First Commonwealth Financial (NYSE:FCF) Rating Increased to Moderate Buy at Raymond James Financial - MarketBeat
Raymond James Reaffirms Their Buy Rating on TowneBank (TOWN) - The Globe and Mail
Raymond James continues to accelerate its Technology & Services Investment Banking practice, hires new Managing Director - marketscreener.com
What You Need To Know Ahead of Raymond James Financial’s Earnings Release - inkl
Raymond James Financial Inc Appoints Michael Baca as Managing Director in Technology & Services Investment Banking Group - MarketScreener
MongoDB (MDB) faces strategic crossroads as AI and data competition intensifies, Raymond James starts with market perform - MSN
Snowflake (SNOW) transforms from cloud data warehouse to AI platform, Raymond James assigns outperform - MSN
MongoDB (MDB) Faces Strategic Crossroads as AI and Data Competition Intensifies, Raymond James Starts With Market Perform - Insider Monkey
Snowflake (SNOW) Transforms From Cloud Data Warehouse to AI Platform, Raymond James Assigns Outperform - Insider Monkey
Raymond James downgrades Citizens Financial Group (CFG) - MSN
Raymond James Upgrades First Bancorp (FBNC) - Nasdaq
Raymond James Upgrade and Organic Growth Story Might Change The Case For Investing In Stryker (SYK) - Yahoo Finance
RAYMOND JAMES FINANCIAL INC ($RJF) Former CEO 2026 Pay Revealed - Quiver Quantitative
GoDaddy’s Airo AI tool sees increased engagement, Raymond James reports By Investing.com - Investing.com South Africa
Raymond James Financial Forecasts Strong Price Appreciation for Aritzia (TSE:ATZ) Stock - MarketBeat
Raymond James raises Tradeweb Markets price target to $138 on long-term potential - Investing.com Australia
Raymond James Adjusts Price Target on Citizens Financial Group to $66 From $62, Maintains Outperform Rating - MarketScreener
Form DEF 14A RAYMOND JAMES FINANCIAL For: Feb 19 - StreetInsider
December Market Review - montgomerycountynews.net
Raymond James Raises Price Target for Webster Financial (WBS) to $73 | WBS Stock News - GuruFocus
Raymond James Raises Price Target for TCBI to $105, Maintains Ou - GuruFocus
Finanzdaten der Raymond James Financial Inc-Aktie (RJF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):